Ajouter à la (aux) collection (s) Ajouter à enregistré
  1. Sciences
  2. Médecine
  3. Cancérologie

Author Manuscript Published OnlineFirst on December 26, 2013; DOI: 10.1158/0008-5472.CAN-13-1750

publicité
publicité
Documents connexes
MSI test - Oncomip
MSI test - Oncomip
BACCALAURÉATS GÉNÉRAL ET TECHNOLOGIQUE
BACCALAURÉATS GÉNÉRAL ET TECHNOLOGIQUE
Main hormone secreting adrenal tumors in dogs and cats
Main hormone secreting adrenal tumors in dogs and cats
IMPORTANT IMMUNOLOGIC CHECKPOINTS IN BREAST CANCER IN FEMALE DOGS INTRODUCTION
IMPORTANT IMMUNOLOGIC CHECKPOINTS IN BREAST CANCER IN FEMALE DOGS INTRODUCTION
Re v i s t a H C PA
Re v i s t a H C PA
MÚdecine_personnalisÚe_-_K-RAS_Erbitux_ou_Vectibix.pptx
MÚdecine_personnalisÚe_-_K-RAS_Erbitux_ou_Vectibix.pptx
The Ribonucleoprotein Pancreatic Ductal Adenocarcinoma Cells 5HYLVHG0DQXVFULSWLQ:RUGRU57) ZLWKFKDQJHVPDUNHG
The Ribonucleoprotein Pancreatic Ductal Adenocarcinoma Cells 5HYLVHG0DQXVFULSWLQ:RUGRU57) ZLWKFKDQJHVPDUNHG
Author Manuscript Published OnlineFirst on April 20, 2012; DOI:10.1158/0008-5472.CAN-11-3768
Author Manuscript Published OnlineFirst on April 20, 2012; DOI:10.1158/0008-5472.CAN-11-3768
Document attach
Document attach
Nanotechnology to Overcome Cancer Drug Resistance Muriel Freixanet Gustà Introduction Aims
Nanotechnology to Overcome Cancer Drug Resistance Muriel Freixanet Gustà Introduction Aims
Combined targeting of EGFR/HER promotes anti-tumor efficacy
Combined targeting of EGFR/HER promotes anti-tumor efficacy
Title: Higher metastatic efficiency of KRas G12V than KRas G13D... Authors (p.o):
Title: Higher metastatic efficiency of KRas G12V than KRas G13D... Authors (p.o):
Téléchargement
publicité